Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 18, 2019 13:08 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Subsidiary Olaregen Therapeutix Sponsors Prestigious Diabetic Limb Salvage Conference in Washington D.C.

Inventor Dr. Lois Chandler, PhD Presents Excellagen® Clinical Trial Data Demonstrating Rapid Healing of Diabetic Neuropathic Foot Ulcers MIRAMAR, FL, April 18, 2019 (GLOBE NEWSWIRE) -- via...
March 29, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million

Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL,...
February 26, 2019 08:00 ET | Source: Generex Biotechnology Corp.

Reminder: Investor Conference Call Today, February 26, 2019; Management to Provide Update on Initiatives & Strategic Plans, Call-in Details

MIRAMAR, FL, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the...
February 15, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Announces Investor Conference Call Agenda; Tuesday, February 26, at 11:00 A.M. Eastern

Management to Provide Update on Strategic Acquisitions, Financing, Growth Initiatives & Spin Out of NuGenerex Immuno-Oncology MIRAMAR, FL, Feb. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
February 12, 2019 09:40 ET | Source: Generex Biotechnology Corp.

Generex Announces Appointment of Marshal Schictman, Esq. as Executive Vice President General Counsel and Corporate SEC Attorney

- Veteran Securities Attorney Joins Management to Guide M&A Initiatives, SEC Regulatory Affairs, and Generex Up-listing MIRAMAR, FL, Feb. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --...
February 04, 2019 13:53 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Responds to Demand for Payment

- Challenges notice from Alpha Capital MIRAMAR, FL, Feb. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT)...
January 23, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Announces REVISED Record Date for NuGenerex Immuno-Oncology Stock Dividend

MIRAMAR, FL , Jan. 23, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that...
January 22, 2019 10:00 ET | Source: Generex Biotechnology Corp.

Generex Biotechnology Provides 2018 Year-End Summary & 2019 Plans

Acquisitions, Financing, Expansion Initiatives & Strategic Plans MIRAMAR, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com)...
January 14, 2019 09:00 ET | Source: Generex Biotechnology Corp.

Generex Announces Investor Conference Call-in Details; Management to Provide Update on Initiatives & Strategic Plans

MIRAMAR, FL, Jan. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) (http://www.otcmarkets.com/stock/GNBT/quote), today announced the...